STRUCTURE AND FUNCTION OF B12-BINDING PROTEINS
B12 结合蛋白的结构和功能
基本信息
- 批准号:3483389
- 负责人:
- 金额:$ 33.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1977
- 资助国家:美国
- 起止时间:1977-07-01 至 1990-11-30
- 项目状态:已结题
- 来源:
- 关键词:DNA binding protein antineoplastics binding proteins chemical structure function chromatography cobamide cofactor gastric juice gastrointestinal nutrient absorption gel electrophoresis glycoproteins human tissue intestinal mucosa intrinsic factor iodination ion transport iron laboratory rabbit methionine adenosyltransferase myeloproliferative neoplasm nitrous oxide nutrition related tag pancreas enzyme protein metabolism radioimmunoassay radiotracer reticulocytes small intestines swine transferrin transport proteins ultracentrifugation vitamin B12 transport defect vitamin metabolism
项目摘要
The objectives are to elucidate the structural and functional properties of
cobalamin (Cb1, vitamin B12)-binding proteins which are involved in the
cellular uptake and utilization of Cb1, and to apply this information to a
number of clinical situations.
We will study the functional significance of the observation that Cb1 is
preferentially bound by R protein in gastric juice and is not transferred
to instrinsic factor until after the R protein moiety is partially degraded
by pancreatic enzymes in the small intestine. We will further define the
role of intrinsic factor and transcobalamin II in the ileal absorption of
Cb1 and study the essentially undefined mechanisms by which Cb1 is released
from cells, with particular emphasis on its release from ileal absorptive
cells and hepatocytes.
We will study the regulation of the two mammalian Cb1-dependent enzymes,
L-methylmalonyl-CoA mutase and methionine synthetase, and elucidate the
pathways involved in the conversion of Cb1 to its coenzyme forms, Ado-Cb1
and CH3-Cb1. We will study the metabolism of methylmalonic acid and
investigate the possibility that it has an important and overlooked
biochemical function.
We will further define the ileal and neutrophil-hepatocyte mechanisms that
prevent the intestinal absorption and tissue dissemination of potentially
toxic Cb1 analogues of bacterial origin and determine if these Cb1
analogues are present in blood and tissues in various diseases. We will
study the properties and origins of a new class of Cb1 analogues that have
recently been observed in human and animal blood and tissues, in
multivitamin-mineral pills and animal chows, and in animals exposed to
nitrous oxide. We will determine the biologic activities and inhibitory
properties of a variety of Cb1 analogues, use them to develop an animal
model of Cb1 deficiency, and investigate their activity as chemotherapeutic
agents against malignant cells.
Methylmalonic acid, homocysteine, and methionine will be assayed in various
blood samples using assays based on capillary gas chromatography-mass
spectrometry. These assays enable the activities of the two mammalian
Cb1-dependent enzymes to be assessed in vivo and will be utilized in
studies involving patients with marked and mild Cb1 deficiency, various
levels of serum Cb1, various neuropsychiatric diseases, and subjects
exposed to nitrous oxide in the work place.
其目的是阐明其结构和功能特性
钴胺(CB1,维生素B12)结合蛋白,参与
细胞对CB1的摄取和利用,并将此信息应用于
临床情况的数量。
我们将研究观察到的CB1的功能意义
优先与胃液中的R蛋白结合,不转移
直到R蛋白部分被部分降解后的内源性因子
通过小肠中的胰酶。我们将进一步定义
内源性因子和转钴胺II在大鼠回肠吸收中的作用
并研究CB1释放的本质上未明确的机制
从细胞中释放,特别强调从回肠吸收中释放
细胞和肝细胞。
我们将研究哺乳动物CB1依赖的两种酶的调节,
L-甲基丙二酰辅酶A变位酶和蛋氨酸合成酶,并阐明了
CB1向辅酶Ado-CB1转化的途径
和CH3-CB1。我们将研究甲基丙二酸的代谢和
调查它是否有一个重要而被忽视的
生化功能。
我们将进一步定义回肠和中性粒细胞-肝细胞的机制
防止潜在的肠道吸收和组织传播
细菌来源的有毒CB1类似物并确定这些CB1
在各种疾病中,血液和组织中都存在类似物。我们会
研究一类新的CB1类似物的性质和起源
最近在人和动物的血液和组织中观察到
复合维生素-矿物质药丸和动物咀嚼,以及暴露于
一氧化二氮。我们将测定其生物活性和抑制力。
各种CB1类似物的性质,用它们来培育动物
CB1缺乏症模型的建立及其化疗活性的研究
抗肿瘤细胞的药物。
甲基丙二酸、同型半胱氨酸和蛋氨酸将在不同的
毛细管气相色谱-质谱法分析血液样品
光谱分析。这些检测使这两种哺乳动物的活动
CB1依赖的酶将在体内进行评估,并将用于
涉及显著和轻度CB1缺乏症患者的研究,各种
血清CB1水平、各种神经精神疾病和受试者
在工作场所暴露于一氧化二氮。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT H ALLEN其他文献
ROBERT H ALLEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT H ALLEN', 18)}}的其他基金
STRUCTURE AND FUNCTION OF B12-BINDING PROTEINS
B12 结合蛋白的结构和功能
- 批准号:
3483386 - 财政年份:1977
- 资助金额:
$ 33.69万 - 项目类别:
STRUCTURE AND FUNCTION OF B12-BINDING PROTEINS
B12 结合蛋白的结构和功能
- 批准号:
3483388 - 财政年份:1977
- 资助金额:
$ 33.69万 - 项目类别:
STRUCTURE AND FUNCTION OF B12-BINDING PROTEINS
B12 结合蛋白的结构和功能
- 批准号:
3483390 - 财政年份:1977
- 资助金额:
$ 33.69万 - 项目类别:
STRUCTURE AND FUNCTION OF B12-BINDING PROTEINS
B12 结合蛋白的结构和功能
- 批准号:
3483387 - 财政年份:1977
- 资助金额:
$ 33.69万 - 项目类别:
STRUCTURE AND FUNCTION OF B12-BINDING PROTEINS
B12 结合蛋白的结构和功能
- 批准号:
3483384 - 财政年份:1977
- 资助金额:
$ 33.69万 - 项目类别:
STRUCTURE AND FUNCTION OF B12-BINDING PROTEINS
B12 结合蛋白的结构和功能
- 批准号:
3151364 - 财政年份:1977
- 资助金额:
$ 33.69万 - 项目类别:
STRUCTURE AND FUNCTION OF B12-BINDING PROTEINS
B12 结合蛋白的结构和功能
- 批准号:
3483385 - 财政年份:1977
- 资助金额:
$ 33.69万 - 项目类别:
相似海外基金
The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
- 批准号:
21K17258 - 财政年份:2021
- 资助金额:
$ 33.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
- 批准号:
499958-2016 - 财政年份:2016
- 资助金额:
$ 33.69万 - 项目类别:
Engage Grants Program
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6623455 - 财政年份:2002
- 资助金额:
$ 33.69万 - 项目类别:
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6465958 - 财政年份:2002
- 资助金额:
$ 33.69万 - 项目类别:
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
- 批准号:
6483914 - 财政年份:2002
- 资助金额:
$ 33.69万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6124630 - 财政年份:1998
- 资助金额:
$ 33.69万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6329037 - 财政年份:1998
- 资助金额:
$ 33.69万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
2747737 - 财政年份:1998
- 资助金额:
$ 33.69万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459680 - 财政年份:1990
- 资助金额:
$ 33.69万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459678 - 财政年份:1990
- 资助金额:
$ 33.69万 - 项目类别: